(CX) Cemex SAB de CV - Ratings and Ratios
Cement, Concrete, Aggregates, Prefabricated, Urbanization
Dividends
| Dividend Yield | 0.80% |
| Yield on Cost 5y | 1.56% |
| Yield CAGR 5y | % |
| Payout Consistency | 36.5% |
| Payout Ratio | 9.3% |
| Risk via 10d forecast | |
|---|---|
| Volatility | 31.7% |
| Value at Risk 5%th | 50.9% |
| Relative Tail Risk | -2.35% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 1.91 |
| Alpha | 79.40 |
| CAGR/Max DD | 0.87 |
| Character TTM | |
|---|---|
| Hurst Exponent | 0.629 |
| Beta | 0.791 |
| Beta Downside | 1.074 |
| Drawdowns 3y | |
|---|---|
| Max DD | 44.37% |
| Mean DD | 16.47% |
| Median DD | 13.08% |
Description: CX Cemex SAB de CV October 30, 2025
CEMEX, S.A.B. de C.V. (NYSE: CX) is a Mexico-based, globally diversified construction materials producer that manufactures and sells cement, ready-mix concrete, aggregates, and a range of urbanization and waste-management services through an integrated network of subsidiaries.
The firm’s product slate includes gray and white Portland cement, oil-well and blended cements, as well as specialty concrete mixes such as rapid-setting, fiber-reinforced, self-consolidating, pervious, and antibacterial varieties. It also markets aggregates (crushed stone, manufactured sand, gravel, recycled concrete) and “vertua” solutions, complemented by logistics, pavement, design-engineering, and industrial construction services.
In 2023 CEMEX reported revenue of roughly $15.5 billion, an adjusted EBITDA margin of 13 %, and a net-debt-to-EBITDA ratio of 2.5×, reflecting a modest improvement in profitability and leverage after a year of price-adjustments and cost-control initiatives.
Key drivers of the business include global cement demand growth of about 5 % YoY, accelerated by infrastructure spending in the United States and emerging-market urbanization; rising input costs for energy and clinker-substitutes, which pressure margins; and a sector-wide shift toward low-carbon “green” cement, where CEMEX’s alternative raw-material solutions could provide a competitive edge.
For a deeper, data-rich analysis of CEMEX’s valuation dynamics, you may find the tools on ValueRay useful for building a more quantitative view.
Piotroski VR‑10 (Strict, 0-10) 6.5
| Net Income (1.36b TTM) > 0 and > 6% of Revenue (6% = 950.3m TTM) |
| FCFTA 0.03 (>2.0%) and ΔFCFTA 1.31pp (YES ≥ +1.0pp, WARN ≥ +0.5pp) |
| NWC/Revenue -3.60% (prev -0.66%; Δ -2.94pp) (YES ≤20% & Δ≤-1pp; WARN ≤25% & Δ≤0 oder ≤40% & Δ≤-3pp) |
| CFO/TA 0.07 (>3.0%) and CFO 2.09b > Net Income 1.36b (YES >=105%, WARN >=100%) |
| Net Debt (1.88b) to EBITDA (2.32b) ratio: 0.81 <= 3.0 (WARN <= 3.5) |
| Current Ratio 0.91 (target 1.5–3.0; WARN 1.2–<1.5 or >3.0–5.0; CFO/TA gate active) |
| Outstanding Shares last Quarter (1.47b) change vs 12m ago -3.11% (target <= -2.0% for YES) |
| Gross Margin 31.66% (prev 33.44%; Δ -1.78pp) >=18% & Δ>=+0.5pp (WARN >=15% & Δ>=0) |
| Asset Turnover 55.57% (prev 58.64%; Δ -3.07pp) >=50% & Δ>=+2pp (WARN >=35% & Δ>=0) |
| Interest Coverage Ratio 3.17 (EBITDA TTM 2.32b / Interest Expense TTM 517.0m) >= 6 (WARN >= 3) |
Altman Z'' 1.39
| (A) -0.02 = (Total Current Assets 5.96b - Total Current Liabilities 6.53b) / Total Assets 29.01b |
| (B) 0.22 = Retained Earnings (Balance) 6.43b / Total Assets 29.01b |
| (C) 0.06 = EBIT TTM 1.64b / Avg Total Assets 28.50b |
| (D) 0.39 = Book Value of Equity 5.91b / Total Liabilities 15.09b |
| Total Rating: 1.39 = (6.56 * A) + (3.26 * B) + (6.72 * C) + (1.05 * D) |
ValueRay F-Score (Strict, 0-100) 65.21
| 1. Piotroski 6.50pt |
| 2. FCF Yield 5.63% |
| 3. FCF Margin 6.33% |
| 4. Debt/Equity 0.23 |
| 5. Debt/Ebitda 0.81 |
| 6. ROIC - WACC (= -0.40)% |
| 7. RoE 10.46% |
| 8. Rev. Trend 36.46% |
| 9. EPS Trend 34.58% |
What is the price of CX shares?
Over the past week, the price has changed by +2.17%, over one month by +6.18%, over three months by +14.15% and over the past year by +87.80%.
Is CX a buy, sell or hold?
- Strong Buy: 3
- Buy: 6
- Hold: 4
- Sell: 1
- Strong Sell: 0
What are the forecasts/targets for the CX price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 11 | 1.5% |
| Analysts Target Price | 11 | 1.5% |
| ValueRay Target Price | 13.4 | 24.1% |
CX Fundamental Data Overview December 06, 2025
P/E Trailing = 12.0659
P/E Forward = 13.3333
P/S = 1.0038
P/B = 1.1604
P/EG = 0.1074
Beta = 1.124
Revenue TTM = 15.84b USD
EBIT TTM = 1.64b USD
EBITDA TTM = 2.32b USD
Long Term Debt = 5.14b USD (from longTermDebt, last quarter)
Short Term Debt = 289.0m USD (from shortTermDebt, last quarter)
Debt = 3.08b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 1.88b USD (from netDebt column, last quarter)
Enterprise Value = 17.81b USD (15.93b + Debt 3.08b - CCE 1.20b)
Interest Coverage Ratio = 3.17 (Ebit TTM 1.64b / Interest Expense TTM 517.0m)
FCF Yield = 5.63% (FCF TTM 1.00b / Enterprise Value 17.81b)
FCF Margin = 6.33% (FCF TTM 1.00b / Revenue TTM 15.84b)
Net Margin = 8.62% (Net Income TTM 1.36b / Revenue TTM 15.84b)
Gross Margin = 31.66% ((Revenue TTM 15.84b - Cost of Revenue TTM 10.82b) / Revenue TTM)
Gross Margin QoQ = 32.12% (prev 33.96%)
Tobins Q-Ratio = 0.61 (Enterprise Value 17.81b / Total Assets 29.01b)
Interest Expense / Debt = 3.58% (Interest Expense 110.3m / Debt 3.08b)
Taxrate = 33.50% (121.0m / 361.3m)
NOPAT = 1.09b (EBIT 1.64b * (1 - 33.50%))
Current Ratio = 0.91 (Total Current Assets 5.96b / Total Current Liabilities 6.53b)
Debt / Equity = 0.23 (Debt 3.08b / totalStockholderEquity, last quarter 13.60b)
Debt / EBITDA = 0.81 (Net Debt 1.88b / EBITDA 2.32b)
Debt / FCF = 1.88 (Net Debt 1.88b / FCF TTM 1.00b)
Total Stockholder Equity = 13.05b (last 4 quarters mean from totalStockholderEquity)
RoA = 4.70% (Net Income 1.36b / Total Assets 29.01b)
RoE = 10.46% (Net Income TTM 1.36b / Total Stockholder Equity 13.05b)
RoCE = 9.02% (EBIT 1.64b / Capital Employed (Equity 13.05b + L.T.Debt 5.14b))
RoIC = 7.47% (NOPAT 1.09b / Invested Capital 14.60b)
WACC = 7.87% (E(15.93b)/V(19.01b) * Re(8.93%) + D(3.08b)/V(19.01b) * Rd(3.58%) * (1-Tc(0.34)))
Discount Rate = 8.93% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: 33.33 | Cagr: 0.75%
[DCF Debug] Terminal Value 74.61% ; FCFE base≈841.0m ; Y1≈815.9m ; Y5≈814.5m
Fair Price DCF = 8.52 (DCF Value 12.36b / Shares Outstanding 1.45b; 5y FCF grow -4.15% → 3.0% )
EPS Correlation: 34.58 | EPS CAGR: 116.1% | SUE: -0.27 | # QB: 0
Revenue Correlation: 36.46 | Revenue CAGR: 4.75% | SUE: 0.07 | # QB: 0
EPS next Quarter (2026-03-31): EPS=0.12 | Chg30d=+0.006 | Revisions Net=+2 | Analysts=3
EPS next Year (2026-12-31): EPS=0.80 | Chg30d=-0.004 | Revisions Net=+3 | Growth EPS=-5.7% | Growth Revenue=+4.8%
Additional Sources for CX Stock
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle